<DOC>
	<DOCNO>NCT01398137</DOCNO>
	<brief_summary>This observational evaluate Total Rhinoconjunctivitis Symptom Score rescue medication usage ( measure Rescue Medication Score Combined Score inform design phase III field study ToleroMune Ragweed .</brief_summary>
	<brief_title>Ragweed Observational Study</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Male female , age 1865 year . Reliable history rhinoconjunctivitis and/or rhinoconjunctivitis plus controlled asthma exposure ragweed allergen least 2 year require symptomatic treatment least 1 year . Positive skin prick test ( SPT ) Ambrosia artemisiifolia Specific Immunoglobulin E ( IgE ) Ambrosia artemisiifolia &gt; 0.35 kU/L Exclusion Criteria Positive skin test confounding , coexist seasonal allergen likely present Preseason baseline ragweed pollen period ( grass , miscellaneous weed , fall tree ) receive medication confound seasonal allergy . Medical record symptomatic perennial allergic rhinitis and/or asthma due allergen subject regularly expose ( mould , dust mite , cockroach , animal dander ) receive medication perennial allergy Subjects history severe drug allergy , severe angioedema anaphylactic reaction food previous SPT allergen . Subjects history significant disease disorder ( e.g. , cardiovascular , pulmonary , gastrointestinal , liver , renal , neurological , immunopathological , musculoskeletal , endocrine , metabolic , malignant , psychiatric , major physical impairment ) , opinion Investigator , may influence subject 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Ragweed allergy</keyword>
</DOC>